AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s DiseaseACI-24 anti-Abeta active ...

“The journey through these phases varies for each person and may cycle, depending on the response to treatment and external stressors,” says Michael Kane, MD, a psychiatrist and the chief medical ...

BARCELONA — For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache. In ...

Please provide your email address to receive an email when new articles are posted on . Treatment with 100 mg of ubrogepant in the prodromal phase prevented development of headaches as soon as 24 ...

Treatment with oral ubrogepant (Ubrelvy) during the migraine prodrome led to more patients being able to function normally, a prespecified secondary endpoint analysis of the phase III PRODROME trial ...

Ubrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet. David W. Dodick, M.D., from the Mayo Clinic in ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Fewer patients who took ubrogepant during the premonitory phase went on to have headache when compared ...

The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of acute migraine to alleviating common prodromal symptoms of migraine ...